Leveraging the power of AI in cancer care
The role of Artificial intelligence in the fight against cancer
Cancer – the hidden pandemic. More than 18 million people are diagnosed every year, and this number is predicted to rise to 30 million by 2040. At the same time, a significant shortage of healthcare workers is to be expected. Artificial Intelligence can play an important role in addressing these challenges and already today plays a key role in the fight against cancer – from early detection, decision-making and therapy planning to actual therapy and follow-up.
An extra pair of eyes
Striving for more precision in breast cancer screening
AI for consistent quality in cancer therapy planning
Being able to adapt treatments based on what we see every day is already showing huge benefits.Trent Aland, Group Director of Medical Physics for Icon Group, Australia
Adapting therapy constantly – with AI
Facts and Figures - AI in Cancer Care
Did you know?
 https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence#heading-One (accessed Feb 7, 2023)
 https://www.who.int/news/item/03-02-2017-early-cancer-diagnosis-saves-lives-cuts-treatment-costs (accessed Mar 28, 2023)
 https://www.ajronline.org/doi/10.2214/AJR.22.27598 (accessed Feb 24, 2023)
 https://www.wcrf.org/cancer-trends/worldwide-cancer-data/ (accessed Mar 10, 2023)
 https://pubs.rsna.org/doi/10.1148/radiol.2018181371 (accessed Feb 8, 2023)
 https://www.bmj.com/content/371/bmj.m4087 / https://www.lshtm.ac.uk/newsevents/news/2020/every-month-delayed-cancer-treatment-can-raise-risk-death-around-10 (accessed Feb 8, 23)
1 AI-Rad Companion consists of several products that are (medical) devices in their own right, and products under development. AI-Rad Companion is not commercially available in all countries. Its future availability cannot be ensured.
2 Transpara from Screenpoint medical is a third-party product. It is not available in all countries. Its future availability cannot be guaranteed.
3 Autocontouring solutions are available to fit various clinical environments: Directly on SOMATOM go.Sim and SOMATOM go.Open Pro, on the workstation with syngo.via RT Image Suite or as a cloud-based solution with AI-Rad Companion Organs RT.
The products and solutions mentioned herein are not available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
Next-Gen AI is an option and available with Transpara®, a third-party product, powered by FusionAI™, ScreenPointMedical; This feature is an option and available with MAMMOVISTA B.smart™MAMMOVISTA B.smart is not commercially available in all countries.
© 2023 Varian Medical Systems, Inc. All rights reserved. Varian and Varian Medical Systems are registered trademarks and RapidPlan and Ethos Therapy are trademarks of Varian Medical Systems, Inc. The names of other companies and products mentioned herein are used for identification purposes only and may be trademarks or registered trademarks of their respective owners.
Autocontouring solutions are available to fit various clinical environments: Directly on SOMATOM go.Sim and SOMATOM go.Open Pro, on the workstation with syngo.via RT Image Suite or as a cloud-based solution with AI-Rad Companion Organs RT.